Why is this ASX 200 stock crashing 30% today?

What's going with this stock? Let's find out why its shares are deep in the red.

| More on:
A man holds his head in his hands, despairing at the bad result he's reading on his computer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healius Ltd (ASX: HLS) shares are ending the week deep in the red.

In morning trade, the ASX 200 stock is down 30% to a 52-week low of $1.07.

As a comparison, the benchmark ASX 200 index is up 0.15% at the time of writing.

Why is this ASX 200 stock crashing 30%?

The good news for shareholders is that today's massive decline in the Healius share price is not because of a bad update nor a broker downgrade.

In fact, today's big decline could arguably be good news for them.

That's because the decline has been driven by the healthcare company's shares going ex-dividend this morning for a very special dividend.

When a share goes ex-dividend, it means that the rights to an upcoming dividend payment are now settled. As a result, anyone buying this ASX 200 stock today will not be entitled to receive the Healius dividend when it is paid to shareholders. Instead, it will stay with the seller of the shares even though they no longer own them.

In light of this, a share price will usually drop to reflect this. After all, you don't want to pay for something that you won't receive.

The Healius dividend

Earlier this week, Healius announced plans to pay a special dividend following the completion of the sale of Lumus Imaging to funds managed by Affinity Equity Partners.

The ASX 200 stock received cash proceeds of $822 million, which represented an $965 million enterprise value when adjusted for the repayment of equipment leases and closing adjustments.

Net proceeds are expected to be in excess of $800 million after all transaction fees, separation costs and other fees.

Unfortunately, not all of these funds will be returned to shareholders, but a good portion will be.

The ASX 200 stock is returning $300 million to shareholders through a fully franked special dividend of 41.3 cents per share. Those franking credits equate to 17.7 cents per share or approximately $128 million.

Based on where the Healius share price finished yesterday's session, this equates to a stunning 26.8% fully franked dividend yield.

To put that into context, a $5,000 investment in its shares yesterday would generate approximately $1,340 in dividends.

When is pay day?

The ASX 200 stock's eligible shareholders won't have to wait long for pay day.

The healthcare company is planning to pay this monster dividend to shareholders in two weeks on 23 May.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Here's the dividend forecast out to 2030 for Sigma shares

This business could pay healthy dividends in the coming years…

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Mayne Pharma signals short-term pain as it resets for growth

It has been a turbulent year for Mayne Pharma after the terminated takeover bid by US company Cosette Pharmaceuticals.

Read more »

A man packs up a box of belongings at his desk as he prepares to leave the office.
Healthcare Shares

Regis Healthcare shares down 2% as CEO resigns

Dr Mellors will step down as CEO after more than six years in the role.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Telix shares storm higher on big US and China news

Let's see why this biotech is getting attention on Monday.

Read more »

A Sonic Healthcare medical researcher wearing a white coat sits at her desk in a laboratory conducting a COVID-19 test
Healthcare Shares

Clinical trial of potential diabetes and arthritis treatment delivers positive results

This drug developer has reported positive results from a phase one trial.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Blue Chip Shares

Is now the time to buy Pro Medicus shares?

After a 13% pullback, Pro Medicus shares are back in focus. Is this weakness an opportunity?

Read more »

Business people discussing project on digital tablet.
Healthcare Shares

Where will CSL shares be in 5 years?

Would it be a good time to buy and hold this fallen giant? Let's find out.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »